Keyphrases
Obesity
100%
Butyrate
100%
Metabolic Disorders
100%
Therapeutic Use
100%
Body Weight Regulation
33%
Insulin Sensitivity
33%
Energy Metabolism
16%
Treatment Outcome
16%
Therapeutic Potential
16%
Evidence-based
16%
Type 2 Diabetes Mellitus (T2DM)
16%
Etiology
16%
Human Studies
16%
Inflammation
16%
Targeted Intervention
16%
Metabolic
16%
Obesity Prevention
16%
Short-chain Fatty Acids
16%
Human Data
16%
Clinical Efficacy
16%
Animal Data
16%
Substrate Metabolism
16%
Gut Microbiome
16%
Anti-inflammatory Properties
16%
Microbial Activity
16%
Focused Intervention
16%
Gut Microbial Community
16%
Control Sensitivity
16%
Obesity-related Complications
16%
Indigestible Carbohydrates
16%
Adipose Tissue Metabolism
16%
Bacterial Fermentation
16%
Microbial Functionality
16%
Obesity Treatment
16%
Impact Treatment
16%
INIS
obesity
100%
therapeutic uses
100%
interventions
80%
data
40%
sensitivity
40%
humans
40%
control
40%
animals
40%
metabolism
40%
inflammation
40%
weight
40%
insulin
40%
increasing
20%
tissues
20%
optimization
20%
fatty acids
20%
energy
20%
populations
20%
disturbances
20%
chains
20%
implementation
20%
etiology
20%
substrates
20%
adipose tissue
20%
carbohydrates
20%
fermentation
20%
Medicine and Dentistry
Butyric Acid
100%
Metabolic Disorder
100%
Therapeutic Use
100%
Insulin Sensitivity
33%
Gut
33%
Body Weight Control
33%
Adipose Tissue
16%
Maturity Onset Diabetes of the Young
16%
Human Study
16%
Short Chain Fatty Acid
16%
Anti-Inflammatory Drug
16%
Tissue Metabolism
16%
Gut Microbiome
16%
Microbial Activity
16%
Immunology and Microbiology
Insulin Sensitivity
100%
Body Weight Control
100%
Animal Experiment
50%
Adipose Tissue
50%
Tissue Metabolism
50%
Gut Microbiome
50%
Microbial Activity
50%
Nursing and Health Professions
Butyric Acid
100%
Body Weight Control
33%
Inflammation
16%
Non Insulin Dependent Diabetes Mellitus
16%
Treatment Outcome
16%
Clinical Effectiveness
16%
Short Chain Fatty Acid
16%
Animal Experiment
16%